These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16321727)

  • 21. Ethics of the early intervention in the treatment of schizophrenia.
    Filaković P; Degmecić D; Koić E; Benić D
    Psychiatr Danub; 2007 Sep; 19(3):209-15. PubMed ID: 17914322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In the aftermath of CATIE: how should administrators value atypical antipsychotic medications?
    Luchins DJ
    Adm Policy Ment Health; 2006 Sep; 33(5):541-3. PubMed ID: 16688482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.
    Olivares JM; Peuskens J; Pecenak J; Resseler S; Jacobs A; Akhras KS;
    Curr Med Res Opin; 2009 Sep; 25(9):2197-206. PubMed ID: 19604073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
    Kasper S
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.
    Cornblatt BA; Lencz T; Smith CW; Olsen R; Auther AM; Nakayama E; Lesser ML; Tai JY; Shah MR; Foley CA; Kane JM; Correll CU
    J Clin Psychiatry; 2007 Apr; 68(4):546-57. PubMed ID: 17474810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample.
    Walker EF; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Heinssen R
    Schizophr Res; 2009 Nov; 115(1):50-7. PubMed ID: 19709859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroleptics in the treatment of schizophrenia in childhood].
    Paclt I
    Cesk Psychiatr; 1993 Jan; 89(1):20-3. PubMed ID: 8099536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of the schizophrenia prodrome: is it presently ethical?
    Cornblatt BA; Lencz T; Kane JM
    Schizophr Res; 2001 Aug; 51(1):31-8. PubMed ID: 11479063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can antidepressants prevent psychosis?
    Fusar-Poli P; Valmaggia L; McGuire P
    Lancet; 2007 Nov; 370(9601):1746-8. PubMed ID: 18037073
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognosis of the effectiveness of pharmacotherapy of patients with acute schizophrenia based on a correlation and regression analysis of clinical and electroencephalographic indices].
    Nemtsov AV; Kalinin VV; Zaĭtsev SG; Golikova TI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 Sep; 82(9):68-73. PubMed ID: 6128846
    [No Abstract]   [Full Text] [Related]  

  • 33. [Maintenance and termination of drug therapy in psychiatry].
    Watanabe M
    Seishin Shinkeigaku Zasshi; 1999; 101(12):1018-23. PubMed ID: 10810606
    [No Abstract]   [Full Text] [Related]  

  • 34. The schizophrenia prodrome: treatment and high-risk perspectives.
    Cornblatt B; Lencz T; Obuchowski M
    Schizophr Res; 2002 Mar; 54(1-2):177-86. PubMed ID: 11853992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In conclusion: does antipsychotic treatment modify the long-term course of schizophrenic illness?
    Tandon R
    J Psychiatr Res; 1998; 32(3-4):251-3. PubMed ID: 9793878
    [No Abstract]   [Full Text] [Related]  

  • 36. Polypharmacy for schizophrenia.
    Ballon J; Stroup TS
    Curr Opin Psychiatry; 2013 Mar; 26(2):208-13. PubMed ID: 23318662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopharmacologic issues in the maintenance treatment of schizophrenia.
    Kane JM; Borenstein M; Woerner M
    Psychopharmacol Bull; 1984; 20(3):423-5. PubMed ID: 6147875
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biological methods of predicting the effectiveness of psychopharmacologic treatment of schizophrenia (review)].
    Nemtsov AV; Kalinin VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1232-41. PubMed ID: 6171962
    [No Abstract]   [Full Text] [Related]  

  • 39. [An attempt to discontinue long-term psychopharmacologic therapy in chronic schizophrenics].
    Klik J; Fait V; Bat'ková Z
    Cesk Psychiatr; 1984 Apr; 80(2):121-4. PubMed ID: 6147204
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of pharmacotherapy for negative symptoms of schizophrenia.
    Hanson E; Healey K; Wolf D; Kohler C
    Curr Psychiatry Rep; 2010 Dec; 12(6):563-71. PubMed ID: 20821286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.